[1] Sheng C, Zhang W. New lead structures in antifungal drug discovery[J]. Curr Med Chem,2011, 18(5):733.
[2] Sheng C, Zhang W, Zhang M, et al. Homology modeling of lanosterol 14-demethylase of Candida albicans and Aspergillus fumigatus and insights into the enzyme-substrate interactions[J]. J Biomol Struct & Dyn, 2004, 22(1):91.
[3] Sheng C, Wang W, Che X, et al. Improved model of lanosterol 14alpha-demethylase by ligand-supported homology modeling:validation by virtual screening and azole optimization. ChemMedChem[J]. 2010, 5(3):390.
[4] Sheng C, Miao Z, Ji H, et al. Three-dimensional model of lanosterol 14 alpha-demethylase from Cryptococcus neoformans:active-site characterization and insights into azole binding[J]. Antimicrob Agents Chemother. 2009, 53(8):3487.
[5] Sheng C, Zhang W, Ji H, et al. Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA and molecular docking[J]. J Med Chem, 2006, 49(8):2512.